173 related articles for article (PubMed ID: 3259672)
21. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
Soltis RD; Hasz DE
J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
[TBL] [Abstract][Full Text] [Related]
22. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
[TBL] [Abstract][Full Text] [Related]
23. Anti-C1q affinity isolated circulating immune complexes correlate with extra-articular rheumatoid disease.
Melsom RD; Horsfall AC; Schrieber L; Charles P; Maini RN
Rheumatol Int; 1986; 6(5):227-31. PubMed ID: 3492027
[TBL] [Abstract][Full Text] [Related]
24. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q.
Hoekzema R; Martens M; Brouwer MC; Hack CE
Mol Immunol; 1988 May; 25(5):485-94. PubMed ID: 3261834
[TBL] [Abstract][Full Text] [Related]
25. Mutual inhibition of the binding of Clq and protein A to rabbit IgG immune complexes.
Laky M; Sjöquist J; Moraru I; Gheţie V
Mol Immunol; 1985 Nov; 22(11):1297-302. PubMed ID: 3878459
[TBL] [Abstract][Full Text] [Related]
26. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes.
Gorgani NN; Parish CR; Easterbrook Smith SB; Altin JG
Biochemistry; 1997 Jun; 36(22):6653-62. PubMed ID: 9184145
[TBL] [Abstract][Full Text] [Related]
27. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome.
Wisnieski JJ; Naff GB
Arthritis Rheum; 1989 Sep; 32(9):1119-27. PubMed ID: 2528353
[TBL] [Abstract][Full Text] [Related]
28. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
29. The relationship between the binding ability and the rate of activation of the complement component C1.
Folkerd EJ; Gardner B; Hughes-Jones NC
Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
[TBL] [Abstract][Full Text] [Related]
30. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
[TBL] [Abstract][Full Text] [Related]
31. Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis.
Smith AJ; Kyle V; Cawston TE; Hazleman BL
Ann Rheum Dis; 1987 Jun; 46(6):468-74. PubMed ID: 2820320
[TBL] [Abstract][Full Text] [Related]
32. Measurement of serum antibodies to C1q and conglutinin in rabbits following feeding with cows' milk and in normal human serum.
Hanglow AC; Welsh CJ; Coombs RR
Adv Exp Med Biol; 1987; 216B():1317-23. PubMed ID: 3501233
[No Abstract] [Full Text] [Related]
33. Co-operation between the pair of C gamma 2 domains in Clq-binding by rabbit IgG.
Udaka K; Okada M; Utsumi S
Mol Immunol; 1986 Oct; 23(10):1103-10. PubMed ID: 3491952
[TBL] [Abstract][Full Text] [Related]
34. Proteins involved in the activation and control of the two pathways of human complement.
Reid KB
Biochem Soc Trans; 1983 Jan; 11(1):1-12. PubMed ID: 6298023
[No Abstract] [Full Text] [Related]
35. The reaction between the complement subcomponent C1q, IgG complexes and polyionic molecules.
Hughes-Jones NC; Gardner B
Immunology; 1978 Mar; 34(3):459-63. PubMed ID: 640715
[TBL] [Abstract][Full Text] [Related]
36. Correlation between circulating antigens detected by the radioimmunoprecipitation-polyethylene glycol assay (RIPEGA) and C1q-binding immune complexes in human schistosomiasis mansoni.
Santoro F; Prata A; Silva AE; Capron A
Am J Trop Med Hyg; 1981 Sep; 30(5):1020-5. PubMed ID: 6974508
[TBL] [Abstract][Full Text] [Related]
37. On the interaction of rabbit C1q with sheep and rabbit immune complexes.
Liberti PA; Baillie RD; Milligan KF; Bausch DM
J Immunol; 1979 Nov; 123(5):2212-9. PubMed ID: 114586
[No Abstract] [Full Text] [Related]
38. Critical aspects of immune complex assays employing polyethylene glycol.
Cooper KM; Moore M
J Immunol Methods; 1983 Jun; 60(3):289-303. PubMed ID: 6602185
[TBL] [Abstract][Full Text] [Related]
39. Activation of C1 by monoclonal antibodies directed against C1q.
Kilchherr E; Schumaker VN; Curtiss LK
Biochem Biophys Res Commun; 1985 Jan; 126(2):785-91. PubMed ID: 3872122
[TBL] [Abstract][Full Text] [Related]
40. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus.
Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
Clin Exp Immunol; 1987 Jul; 69(1):98-106. PubMed ID: 3498589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
